{"protocolSection":{"identificationModule":{"nctId":"NCT00047580","orgStudyIdInfo":{"id":"ELN021-502"},"organization":{"fullName":"Elan Pharmaceuticals","class":"INDUSTRY"},"briefTitle":"Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.","officialTitle":"A Multicenter, Open-Label, Randomized, 4-Way Crossover Trial of the Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex (Tizanidine Hydrochloride) Tablets Taken Under Fed and Fasted Conditions in Patients With Moderate to Severe Spasticity"},"statusModule":{"statusVerifiedDate":"2015-12","overallStatus":"COMPLETED","startDateStruct":{"date":"2002-06"},"completionDateStruct":{"date":"2002-09"},"studyFirstSubmitDate":"2002-10-08","studyFirstSubmitQcDate":"2002-10-09","studyFirstPostDateStruct":{"date":"2002-10-10","type":"ESTIMATED"},"lastUpdateSubmitDate":"2015-12-10","lastUpdatePostDateStruct":{"date":"2015-12-14","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"leadSponsor":{"name":"Elan Pharmaceuticals","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"This study is being conducted to compare the impact of somnolence (sleepiness) on cognition (awareness) as well as the safety and effectiveness of tizanidine hydrochloride capsules versus Zanaflex® (tizanidine hydrochloride tablets) taken while in the fed state (just after a meal) and in the fasted state (before a meal) in patients with moderate to severe spasticity."},"conditionsModule":{"conditions":["Multiple Sclerosis","Muscle Spasticity","Spinal Cord Injury","Stroke"],"keywords":["Spasticity","spasticity secondary to Multiple Sclerosis","Spinal Cord Injury","Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":120}},"armsInterventionsModule":{"interventions":[{"type":"DRUG","name":"tizanidine hydrochloride capsule"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* IRB approved ICF must be signed and dated by patient or patient's legal representative\n* Male or Female 18 years of age or older\n* Clinical diagnosis of established spasticity (at least 3 months) secondary to multiple sclerosis, stroke, or spinal cord injury\n* Currently on stable dose of up to 36mg of Zanaflex\n* Must be able to swallow tablets or capsules whole\n\nExclusion Criteria:\n\n* Patients with dementia, aphasia, or other deficits in cognition\n* Unwilling or unable to complete cognition test or daily diary\n* Known sensitivity to Zanaflex\n* Taking Zanaflex on an as needed (\"prn\") basis\n* Currently being treated with drugs having significant effects at the alpha2 receptors whether agonist (i.e., clonidine, methyldopa) or antagonist (i.e., phenothiazines, imipramine)\n* Currently on any other muscle relaxant or any drugs having muscle relaxant properties (including baclofen, dantrolene, diazepam and other benzodiazepines, tranquilizers, narcotic analgesics, high dose neuroleptics, chlormezanone, meprobamate, methocarbamol, orphenadrine, carisoprodol, gabapentin and clonidine\n* Taking any over-the-counter or prescription sleep aids within 30 days prior to screening\n* Use of illegal drugs or legal drugs for recreational purposes or excessive use of alcohol\n* Patients suffering from disabling, symptomatic hypotension (i.e., syncope)\n* Patients having any systemic disease such as renal insufficiency, clinically relevant elevations in hepatic transaminase, severe, uncontrolled systemic hypertension\n* Any clinically significant illnesses, within four weeks of screening\n* Patients with known sleep disorders\n* Patients who participated in a clinical trial within thiry days prior to screening\n* Women of childbearing potential who are pregnant, have a positive serum pregnancy test, lactating, or do not or will not take adequate contraceptive precautions for the duration of trial","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Radiant Research","city":"Tucson","state":"Arizona","zip":"85710","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"The Neurology Center","city":"Encinitas","state":"California","zip":"92024","country":"United States","geoPoint":{"lat":33.03699,"lon":-117.29198}},{"facility":"Northridge Neurological Center","city":"Northridge","state":"California","zip":"91325","country":"United States","geoPoint":{"lat":34.22834,"lon":-118.53675}},{"facility":"The Neurology Center","city":"Oceanside","state":"California","zip":"92056","country":"United States","geoPoint":{"lat":33.19587,"lon":-117.37948}},{"facility":"Neurology Medical Group of Diablo Valley","city":"Walnut Creek","state":"California","zip":"94598","country":"United States","geoPoint":{"lat":37.90631,"lon":-122.06496}},{"facility":"Colorado Neurology Movement Disorders Center","city":"Englewood","state":"Colorado","zip":"80110","country":"United States","geoPoint":{"lat":39.64777,"lon":-104.98776}},{"facility":"Yale Center for MS Treatment and Research","city":"New Haven","state":"Connecticut","zip":"06510","country":"United States","geoPoint":{"lat":41.30815,"lon":-72.92816}},{"facility":"Neurology Clinic Research Institution","city":"Plantation","state":"Florida","zip":"33324","country":"United States","geoPoint":{"lat":26.13421,"lon":-80.23184}},{"facility":"Axiom Clinical Research","city":"Tampa","state":"Florida","zip":"33609","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}},{"facility":"Comprehensive Neurology Specialists, PC","city":"Atlanta","state":"Georgia","zip":"30338","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Neurotrials Research, Inc.","city":"Atlanta","state":"Georgia","zip":"30342","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Springfield Clinic Neuroscience Institute","city":"Springfield","state":"Illinois","zip":"62702","country":"United States","geoPoint":{"lat":39.80172,"lon":-89.64371}},{"facility":"The Minneapolis Clinic of Neurology, Ltd.","city":"Minneapolis","state":"Minnesota","zip":"55422","country":"United States","geoPoint":{"lat":44.97997,"lon":-93.26384}},{"facility":"Neurological Associates of Tulsa, Inc.","city":"Tulsa","state":"Oklahoma","zip":"74136-8327","country":"United States","geoPoint":{"lat":36.15398,"lon":-95.99277}},{"facility":"Medford Neurological and Spine Clinic","city":"Medford","state":"Oregon","zip":"97504-8456","country":"United States","geoPoint":{"lat":42.32652,"lon":-122.87559}},{"facility":"Sargent Rehabilitation Center","city":"Warwick","state":"Rhode Island","zip":"02818","country":"United States","geoPoint":{"lat":41.7001,"lon":-71.41617}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000009128","term":"Muscle Spasticity"},{"id":"D000009103","term":"Multiple Sclerosis"},{"id":"D000013119","term":"Spinal Cord Injuries"},{"id":"D000012598","term":"Sclerosis"}],"ancestors":[{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020278","term":"Demyelinating Autoimmune Diseases, CNS"},{"id":"D000020274","term":"Autoimmune Diseases of the Nervous System"},{"id":"D000003711","term":"Demyelinating Diseases"},{"id":"D000001327","term":"Autoimmune Diseases"},{"id":"D000007154","term":"Immune System Diseases"},{"id":"D000013118","term":"Spinal Cord Diseases"},{"id":"D000020196","term":"Trauma, Nervous System"},{"id":"D000014947","term":"Wounds and Injuries"},{"id":"D000009135","term":"Muscular Diseases"},{"id":"D000009140","term":"Musculoskeletal Diseases"},{"id":"D000009122","term":"Muscle Hypertonia"},{"id":"D000020879","term":"Neuromuscular Manifestations"},{"id":"D000009461","term":"Neurologic Manifestations"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M11997","name":"Neoplasm Metastasis","relevance":"LOW"},{"id":"M15606","name":"Spinal Cord Injuries","asFound":"Spinal Cord Injury","relevance":"HIGH"},{"id":"M11750","name":"Multiple Sclerosis","asFound":"Multiple Sclerosis","relevance":"HIGH"},{"id":"M15105","name":"Sclerosis","asFound":"Sclerosis","relevance":"HIGH"},{"id":"M24996","name":"Malnutrition","relevance":"LOW"},{"id":"M11775","name":"Muscle Spasticity","asFound":"Spasticity","relevance":"HIGH"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M4319","name":"Autoimmune Diseases","relevance":"LOW"},{"id":"M21788","name":"Demyelinating Autoimmune Diseases, CNS","relevance":"LOW"},{"id":"M21784","name":"Autoimmune Diseases of the Nervous System","relevance":"LOW"},{"id":"M6599","name":"Demyelinating Diseases","relevance":"LOW"},{"id":"M9890","name":"Immune System Diseases","relevance":"LOW"},{"id":"M15605","name":"Spinal Cord Diseases","relevance":"LOW"},{"id":"M17375","name":"Wounds and Injuries","relevance":"LOW"},{"id":"M21713","name":"Trauma, Nervous System","relevance":"LOW"},{"id":"M11782","name":"Muscular Diseases","relevance":"LOW"},{"id":"M11787","name":"Musculoskeletal Diseases","relevance":"LOW"},{"id":"M11769","name":"Muscle Hypertonia","relevance":"LOW"},{"id":"M22309","name":"Neuromuscular Manifestations","relevance":"LOW"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC04","name":"Neoplasms"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC26","name":"Wounds and Injuries"},{"abbrev":"BC20","name":"Immune System Diseases"},{"abbrev":"BC18","name":"Nutritional and Metabolic Diseases"},{"abbrev":"BC05","name":"Musculoskeletal Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"C000023754","term":"Tizanidine"}],"ancestors":[{"id":"D000000700","term":"Analgesics"},{"id":"D000018689","term":"Sensory System Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000000927","term":"Anticonvulsants"},{"id":"D000009125","term":"Muscle Relaxants, Central"},{"id":"D000009465","term":"Neuromuscular Agents"},{"id":"D000010276","term":"Parasympatholytics"},{"id":"D000001337","term":"Autonomic Agents"},{"id":"D000058647","term":"Adrenergic alpha-2 Receptor Agonists"},{"id":"D000000316","term":"Adrenergic alpha-Agonists"},{"id":"D000000322","term":"Adrenergic Agonists"},{"id":"D000018663","term":"Adrenergic Agents"},{"id":"D000018377","term":"Neurotransmitter Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"}],"browseLeaves":[{"id":"M225226","name":"Tizanidine","asFound":"Healed","relevance":"HIGH"},{"id":"M13251","name":"Phenylephrine","relevance":"LOW"},{"id":"M12721","name":"Oxymetazoline","relevance":"LOW"},{"id":"M3722","name":"Analgesics","relevance":"LOW"},{"id":"M3936","name":"Anticonvulsants","relevance":"LOW"},{"id":"M12879","name":"Parasympatholytics","relevance":"LOW"},{"id":"M20436","name":"Adrenergic Agents","relevance":"LOW"},{"id":"M3358","name":"Adrenergic alpha-Agonists","relevance":"LOW"},{"id":"M3363","name":"Adrenergic Agonists","relevance":"LOW"},{"id":"M20194","name":"Neurotransmitter Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"Analg","name":"Analgesics"},{"abbrev":"AntiConv","name":"Anticonvulsants"},{"abbrev":"MuRelCen","name":"Muscle Relaxants, Central"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"CaAg","name":"Cardiotonic Agents"},{"abbrev":"VaCoAg","name":"Vasoconstrictor Agents"},{"abbrev":"Resp","name":"Respiratory System Agents"}]}},"hasResults":false}